Patent details

Basic Information

Publication number:

EP2601969

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131575722

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Norovirus vaccine formulations

French Title of Invention:

FORMULATIONS DE VACCIN CONTRE UN NOROVIRUS

German Title of Invention:

NOROVIRUS-IMPFSTOFF-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

28/09/2007

Grant date:

30/03/2016

EP Publication Date:

30/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/06/2013

EP B1 Publication Date:

30/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/09/2016

Expiration date:

28/09/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/09/2007

 

 

Name:

Takeda Vaccines Inc.

Address:

One Takeda Parkway, Deerfield, IL 60015, United States (US)

Inventor

1

Name:

Foubert Thomas R.

Address:

United States (US)

2

Name:

Richardson Charles

Address:

United States (US)

3

Name:

Tino William T.

Address:

United States (US)

4

Name:

Vedvick Thomas S.

Address:

United States (US)

Priority

1

Priority Number:

847912 P

Priority Date:

29/09/2006

Priority Country:

United States (US)

2

Priority Number:

973392 P

Priority Date:

18/09/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/42;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages